Perrigo to acquire US OTC rights to Prevacid

9 September 2019 - Deborah Wilkes

Premium

Perrigo is acquiring the US OTC rights to Prevacid 24HR (lansoprazole) from GlaxoSmithKline for an undisclosed sum. The company said the deal advanced its "Consumer Self-Care growth strategy".

Click tags below for more information on topics:

GlaxoSmithKline Perrigo

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: